Value Bridge — MASSACHUSETTS GENERAL HOSPITAL
Current $-175M → Target $-98M (+$77.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-175.2M
Current EBITDA
$-97.8M
Target EBITDA
+$77.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$17.5M
Payer Mix Optimization
$42.0M
Cost to Collect Reduction
$14.0M
Clean Claim Improvement
$10.5M
Volume & Rate Growth
$70.1M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-175M to $-98M. The highest-impact lever is Volume & Rate Growth at $28.0M probability-weighted.
IC talking point: "We see $77M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $852M in equity value creation."